Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

This study has been withdrawn prior to enrollment.
(Change in research focus)
Sponsor:
Collaborators:
Caring for Carcinoid Foundation
GI Cancer Research Gift Fund
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01031056
First received: December 10, 2009
Last updated: May 24, 2012
Last verified: May 2012
  Purpose

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers.

PRIMARY OBJECTIVES:

1. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers.

SECONDARY OBJECTIVES:

  1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories
  2. Collect details about the tumor specimen extracted from patient charts.

Condition Intervention
Gastrointestinal Neoplasms
Gynecologic Cancers
Gynecologic Cancers Cervical Cancer
Gastric (Stomach) Cancer
Gastro-Esophageal(GE) Junction Cancer
Gastrointenstinal Stromal Tumor (GIST)
Colon/Rectal Cancer
Colon/Rectal Cancer Colon Cancer
Colon/Rectal Cancer Rectal Cancer
Colon/Rectal Cancer Anal Cancer
Anal Cancer
Hepatobiliary Cancers
Hepatobiliary Cancers Liver
Pancreatic Cancer
Procedure: Blood Draw
Procedure: Frozen Tumor Specimens

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Collection of Biospecimen and Clinical Information in Patients With Gastrointestinal Cancers

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • None: Biospecimen will be collected for future research. [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

This study requires that we obtain archived tumor and normal tissue and blood.


Enrollment: 0
Study Start Date: January 2010
Estimated Study Completion Date: January 2099
Estimated Primary Completion Date: January 2099 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with gastrointestinal cancer.

Criteria

Inclusion Criteria:1. Patients are eligible if they have a histologically proven gastrointestinal cancer (esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor).

2. 18 years of age or older

3. Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:None

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01031056

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Caring for Carcinoid Foundation
GI Cancer Research Gift Fund
Investigators
Principal Investigator: Teri A Longacre M.D. Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01031056     History of Changes
Other Study ID Numbers: SU-09092009-3840, GI0004
Study First Received: December 10, 2009
Last Updated: May 24, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anus Neoplasms
Neoplasms
Colonic Neoplasms
Rectal Neoplasms
Uterine Cervical Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Pancreatic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Anus Diseases
Rectal Diseases
Colonic Diseases
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Endocrine Gland Neoplasms
Pancreatic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 29, 2014